New pro-oxidant supplement shows promise in slowing prostate cancer progression

Prostate cancer is a quiet killer. In most men, it’s treatable. However, in some cases, it resists all known therapies and turns extremely deadly.

First Choice Neurology to Deploy healow Genie’s AI Contact Center

What You Should Know: – First Choice Neurology, the largest neurology center in Florida, has partnered with eClinicalWorks® to implement healow® Genie, an AI-powered contact

February 28, 2025

San Diego biotech Neurocrine Biosciences joins PhRMA

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday. The addition is

February 22, 2024

UT Health San Antonio achieves top global ranking for research and clinical medicine

The race to draw the best and brightest students has become an international one, with candidates weighing options not only in their state or country,

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.